Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic and predictive implications of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) expression in breast cancer.
Kouvaraki M, Zerdes I, Sifakis EG, Sarafidis M, Matikas A, Tzoras E, Kjällquist U, Stathopoulou K, Lövrot J, Alkodsi A, Hartman J, Sotiriou C, Richard F, Hatschek T, Herold N, Bergh J, Rassidakis GZ, Foukakis T. Kouvaraki M, et al. Among authors: sifakis eg. Int J Cancer. 2024 Dec 27. doi: 10.1002/ijc.35319. Online ahead of print. Int J Cancer. 2024. PMID: 39729390
PIK3CA mutations in endocrine-resistant breast cancer.
Schagerholm C, Robertson S, Toosi H, Sifakis EG, Hartman J. Schagerholm C, et al. Among authors: sifakis eg. Sci Rep. 2024 May 31;14(1):12542. doi: 10.1038/s41598-024-62664-1. Sci Rep. 2024. PMID: 38822093 Free PMC article.
Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images.
Tsiknakis N, Manikis G, Tzoras E, Salgkamis D, Vidal JM, Wang K, Zaridis D, Sifakis E, Zerdes I, Bergh J, Hartman J, Acs B, Marias K, Foukakis T. Tsiknakis N, et al. IEEE J Biomed Health Inform. 2024 Sep;28(9):5312-5322. doi: 10.1109/JBHI.2024.3413533. Epub 2024 Sep 5. IEEE J Biomed Health Inform. 2024. PMID: 38865229
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer.
Wang K, Zerdes I, Johansson HJ, Sarhan D, Sun Y, Kanellis DC, Sifakis EG, Mezheyeuski A, Liu X, Loman N, Hedenfalk I, Bergh J, Bartek J, Hatschek T, Lehtiö J, Matikas A, Foukakis T. Wang K, et al. Among authors: sifakis eg. Nat Commun. 2024 May 7;15(1):3837. doi: 10.1038/s41467-024-47932-y. Nat Commun. 2024. PMID: 38714665 Free PMC article.
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction.
Chen X, Sifakis EG, Robertson S, Neo SY, Jun SH, Tong L, Hui Min AT, Lövrot J, Hellgren R, Margolin S, Bergh J, Foukakis T, Lagergren J, Lundqvist A, Ma R, Hartman J. Chen X, et al. Among authors: sifakis eg. Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2209856120. doi: 10.1073/pnas.2209856120. Epub 2022 Dec 27. Proc Natl Acad Sci U S A. 2023. PMID: 36574653 Free PMC article.
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Zerdes I, Sifakis EG, Matikas A, Chrétien S, Tobin NP, Hartman J, Rassidakis GZ, Bergh J, Foukakis T. Zerdes I, et al. Among authors: sifakis eg. Mol Oncol. 2020 May;14(5):951-963. doi: 10.1002/1878-0261.12654. Epub 2020 Mar 20. Mol Oncol. 2020. PMID: 32115850 Free PMC article.
19 results